AR042906A1 - Espuma de fosfato de clindamicina sensible a la temperatura y metodo de tratamiento de acne que la utiliza - Google Patents

Espuma de fosfato de clindamicina sensible a la temperatura y metodo de tratamiento de acne que la utiliza

Info

Publication number
AR042906A1
AR042906A1 ARP040100187A ARP040100187A AR042906A1 AR 042906 A1 AR042906 A1 AR 042906A1 AR P040100187 A ARP040100187 A AR P040100187A AR P040100187 A ARP040100187 A AR P040100187A AR 042906 A1 AR042906 A1 AR 042906A1
Authority
AR
Argentina
Prior art keywords
temperature sensitive
clindamycin phosphate
treatment method
method used
acne treatment
Prior art date
Application number
ARP040100187A
Other languages
English (en)
Inventor
Albert Zorko Abram
Barry Thomas Hunt
Original Assignee
Connetics Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32776128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR042906(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Connetics Australia Pty Ltd filed Critical Connetics Australia Pty Ltd
Publication of AR042906A1 publication Critical patent/AR042906A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Composiciones de suministro tópico farmacéuticamente activas. Las composiciones están presentes en un envase presurizado que comprende un agente espumante alcohólico de desintegración rápida, de modo tal que cuando se libera la composición, es decir se suministra, del envase presurizado, se forma una espuma sensible a la temperatura de desintegración rápida. Se describen métodos para modular las características de la espuma y métodos para mejorar la estabilidad del fosfato de clindamicina, método para el tratamiento percutáneo del acné.
ARP040100187A 2003-01-24 2004-01-23 Espuma de fosfato de clindamicina sensible a la temperatura y metodo de tratamiento de acne que la utiliza AR042906A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44228003P 2003-01-24 2003-01-24
US45483203P 2003-03-13 2003-03-13

Publications (1)

Publication Number Publication Date
AR042906A1 true AR042906A1 (es) 2005-07-06

Family

ID=32776128

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP040100187A AR042906A1 (es) 2003-01-24 2004-01-23 Espuma de fosfato de clindamicina sensible a la temperatura y metodo de tratamiento de acne que la utiliza
ARP110102768A AR082432A2 (es) 2003-01-24 2011-08-01 Espuma de fosfato de clindamicina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP110102768A AR082432A2 (es) 2003-01-24 2011-08-01 Espuma de fosfato de clindamicina

Country Status (16)

Country Link
US (6) US7141237B2 (es)
EP (2) EP1592420B1 (es)
JP (2) JP4828404B2 (es)
AR (2) AR042906A1 (es)
AU (2) AU2004206769B2 (es)
BR (1) BRPI0406905B8 (es)
CA (1) CA2513773C (es)
EA (2) EA009031B1 (es)
ES (2) ES2637956T3 (es)
IL (2) IL169761A (es)
MX (1) MXPA05007722A (es)
NO (1) NO339620B1 (es)
NZ (1) NZ541526A (es)
RS (1) RS20050557A (es)
TW (2) TWI355267B (es)
WO (1) WO2004064833A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486394B2 (en) 2003-01-24 2016-11-08 Stiefel West Coast, Llc Pharmaceutical foam

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20050008576A1 (en) * 2002-04-01 2005-01-13 Munzer Makansi Carrier foam to enhance liquid functional performance
US20050239675A1 (en) * 2002-04-01 2005-10-27 Munzer Makansi Carrier foam to enhance liquid functional performance
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
US20040043946A1 (en) * 2002-09-03 2004-03-04 Popp Karl F. Topical formulations for treatment of skin disorders
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
EP1556009B2 (en) 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7575739B2 (en) * 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
EA200600666A1 (ru) 2003-09-29 2006-10-27 Этена Хелткеа Инк. Гелеобразные и пенистые композиции с высоким содержанием спирта
US20050123484A1 (en) * 2003-10-02 2005-06-09 Collegium Pharmaceutical, Inc. Non-flammable topical anesthetic liquid aerosols
US20060188449A1 (en) * 2003-10-03 2006-08-24 Jane Hirsh Topical aerosol foams
US8571648B2 (en) * 2004-05-07 2013-10-29 Aesthera Apparatus and method to apply substances to tissue
FR2877842B1 (fr) * 2004-11-13 2008-12-12 Unilever Nv Naamlooze Vennoots Produit aerosol anti-transpirant
DE102004062775A1 (de) 2004-12-21 2006-06-29 Stockhausen Gmbh Alkoholischer Pumpschaum
EP3292757A1 (en) 2005-03-07 2018-03-14 Deb IP Limited High alcohol content foaming compositions with silicone-based surfactants
CA2610662A1 (en) 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
JP5612263B2 (ja) * 2005-06-01 2014-10-22 スティーフェル リサーチ オーストラリア ピーティーワイ リミテッド ビタミン製剤
EP1919449A2 (en) * 2005-06-07 2008-05-14 Foamix Ltd. Antibiotic kit and composition and uses thereof
WO2007050543A2 (en) * 2005-10-24 2007-05-03 Collegium Pharmaceutical, Inc. Topical pharmaceutical foam composition
US20070224143A1 (en) * 2006-03-21 2007-09-27 Kamedis Ltd. Cosmetic and pharmaceutical foam carrier
EP2010133B1 (en) * 2006-03-31 2016-05-04 Stiefel Research Australia Pty Ltd Foamable suspension gel
WO2008075207A2 (en) * 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
US8580860B2 (en) * 2007-02-23 2013-11-12 Gojo Industries, Inc. Foamable alcoholic composition
US20080287373A1 (en) * 2007-05-17 2008-11-20 Popp Karl F Topical skin treating kits
US20090012434A1 (en) * 2007-07-03 2009-01-08 Anderson Robert S Apparatus, method, and system to treat a volume of skin
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090069795A1 (en) * 2007-09-10 2009-03-12 Anderson Robert S Apparatus and method for selective treatment of tissue
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
DE102008006416A1 (de) 2008-01-28 2009-07-30 Mayer, Thomas, Dr. med. Clindamycin zur Verwendung bei der Behandlung oder Vorbeugung der bakteriellen Vaginosis
US8288434B2 (en) 2008-06-05 2012-10-16 Dow Pharmaceutical Sciences, Inc. Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
WO2010019953A1 (en) 2008-08-15 2010-02-18 Arcion Therapeutics, Inc. High concentration local anesthetic formulations for treating non-neuropathic pain
CA2646932A1 (fr) * 2008-12-10 2010-06-10 Lancelot Biotech Inc. Methode pour l'application topique d'une formulation medicamenteuse
CA2752070C (en) * 2009-02-12 2017-11-28 Precision Dermatology, Inc. Foamable benzoyl peroxide compositions for topical administration
PT2400951T (pt) * 2009-02-25 2018-11-26 Mayne Pharma Llc Composições de espuma tópica
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CN102665734A (zh) * 2009-09-25 2012-09-12 法马索尔有限公司 皮肤用表面涂层
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
EP2563336A4 (en) * 2010-03-26 2014-07-23 Prec Dermatology Inc AEROSOL FOAMS COMPRISING CLINDAMYCIN PHOSPHATE
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
FR2969493B1 (fr) * 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant du bpo
WO2013003236A1 (en) * 2011-06-30 2013-01-03 Allergan, Inc. Retinoid topical compositions and methods for treating skin conditions
EP2741733A4 (en) * 2011-08-11 2015-04-08 Stiefel Res Australia Pty Ltd TOPICAL ANTI-OXIDANT COMPOSITIONS
US8486463B1 (en) 2012-05-09 2013-07-16 L'oreal Cosmetic composition comprising aloe vera and caprylyl salicylic acid and method of making
WO2014011893A1 (en) 2012-07-11 2014-01-16 Mercy Medical Research Institute Colorectal delivery device
US20160008282A1 (en) 2013-02-22 2016-01-14 The Board Of Trustees Of The Universityof Illinois Transdermal Drug Delivery Using Amphiphilic Dendron-Coil Micelles
ES2702646T3 (es) * 2014-03-28 2019-03-04 Galderma Res & Dev Espuma química no enjuagada que contiene adapaleno y peróxido de benzoílo
US9895311B2 (en) 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
US9265727B1 (en) * 2015-01-14 2016-02-23 Delcor Asset Corporation Spray foam corticosteroid product
NZ738815A (en) 2015-07-13 2019-10-25 Dr Reddy’s Laboratories Ltd Topical retinoid compositions
FR3041541B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee comprenant de l'ivermectine
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
WO2018129555A1 (en) 2017-01-09 2018-07-12 Temple University - Of The Commonwealth System Of Higher Education Methods and compositions for treatment of non-alcoholic steatohepatitis
EP3628002B1 (en) 2017-05-23 2023-03-22 Pharmiva AB Foam-forming compositions for delivering an active to a body cavity
EP3641725A1 (en) 2017-06-23 2020-04-29 The Procter and Gamble Company Composition and method for improving the appearance of skin
CN112292158A (zh) * 2018-05-19 2021-01-29 加里·本雅明 泡沫制剂和向身体递送的方法
EP3817717A1 (en) 2018-07-03 2021-05-12 The Procter & Gamble Company Method of treating a skin condition
KR20220042200A (ko) 2019-07-29 2022-04-04 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 상처 치유 촉진용 조성물 및 방법
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
JP2023528616A (ja) 2020-06-01 2023-07-05 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法

Family Cites Families (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3487068A (en) 1966-12-16 1969-12-30 Upjohn Co Lincomycin-2-phosphates,7-substituted compounds and salts thereof
US3475407A (en) 1967-12-22 1969-10-28 Upjohn Co Process for preparing 7(r)- and 7(s)-halolincomycins
US3509127A (en) 1968-04-30 1970-04-28 Upjohn Co Isologs of lincomycins and process for preparing the same
US3544551A (en) 1968-04-30 1970-12-01 Upjohn Co 7-mercapto-7-deoxylincomycins and process for preparing the same
US3513155A (en) 1968-05-07 1970-05-19 Upjohn Co Sulfoxides of 7-halo-7-deoxylincomycins and process
US3580904A (en) 1969-04-03 1971-05-25 Upjohn Co 7-halo-7-deoxy-lincomycin derivatives
US3714141A (en) 1970-05-26 1973-01-30 Upjohn Co Process for making 7-halolincomycins
US3655885A (en) 1970-06-10 1972-04-11 Upjohn Co Antibacterial compositions and methods of treating bacterial infections
US3969516A (en) 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
JPS5271052A (en) 1975-12-08 1977-06-14 Tooyoo Daiyamondo Kougiyou Kk Chain block
IL52045A (en) * 1976-08-25 1979-12-30 Mundipharma Ag Sprayable germicidal foam compositions
AU565146B2 (en) 1983-10-24 1987-09-03 Connetics Australia Pty Ltd Foamable biocide composition
US4568741A (en) 1984-05-15 1986-02-04 The Upjohn Company Synthesis of 7-halo-7-deoxylincomycins
WO1986000196A1 (en) 1984-06-21 1986-01-16 Soltec Research Pty. Ltd. Aerosol product
CN1004002B (zh) 1984-11-29 1989-04-26 厄普约翰公司 制备7-卤-7-去氧林可霉素及其类似化合物的改进方法
US4806262A (en) 1985-08-14 1989-02-21 The Procter & Gamble Company Nonlathering cleansing mousse with skin conditioning benefits
US5446028A (en) * 1985-12-12 1995-08-29 Dermik Laboratories, Inc. Anti-acne method and composition
US4882182A (en) 1987-01-08 1989-11-21 Soltec Research Pty. Ltd. Aerosol product
US4920101A (en) 1987-09-30 1990-04-24 Nelson Research & Development Co. Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
AU619256B2 (en) 1988-03-03 1992-01-23 Connetics Australia Pty Ltd Acne treatment
DK0414920T3 (da) 1989-03-17 1997-12-15 Taisho Pharmaceutical Co Ltd Aerosolpræparater til udvortes brug
DE69020900T2 (de) 1989-07-28 1995-12-14 Hisamitsu Pharmaceutical Co Schaumaerosolzusammensetzung.
JP3140460B2 (ja) 1990-09-03 2001-03-05 ソルテック リサーチ プロプライアタリィ リミティド 濃縮したエーロゾルスペーススプレー
US5935554A (en) 1990-09-03 1999-08-10 Soltec Research Pty. Ltd. Concentrated aerosol space spray that is not an emulsion
GB9111477D0 (en) * 1991-05-29 1991-07-17 Sandoz Ltd Pharmaceutical composition
FR2677369B1 (fr) * 1991-06-05 1994-09-16 Promotion Rech Innovation Tec Mousse aerosol.
JPH05271052A (ja) * 1992-03-26 1993-10-19 Dotsuto:Kk 尋常性ザ瘡治療用ローション
US5635469A (en) * 1993-06-10 1997-06-03 The Procter & Gamble Company Foaming cleansing products
SK279919B6 (sk) * 1993-07-01 1999-05-07 Yamanouchi Europe B.V. Farmaceutický a kozmetický prostriedok na miestne
US5466446A (en) * 1994-02-16 1995-11-14 Stiefel Laboratories, Inc. Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
FR2722098B1 (fr) 1994-07-06 1996-08-23 Cird Galderma Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine
US5679324A (en) * 1994-07-08 1997-10-21 The Procter & Gamble Co. Aerosol foamable fragrance composition
US5776430A (en) 1994-11-01 1998-07-07 Calgon Vestal, Inc. Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US5783202A (en) 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
FR2740685B1 (fr) 1995-11-08 1998-01-23 Pf Medicament Composition pharmaceutique topique moussante pour le traitement des dermatoses, induites par pityrosporum ovale
US5788155A (en) 1996-06-28 1998-08-04 S. C. Johnson & Son, Inc. Air freshener dispenser device with dual cartridge capacity
AUPO379596A0 (en) 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
US5843881A (en) * 1997-02-13 1998-12-01 The Procter & Gamble Company Spray compositions
AUPO688997A0 (en) 1997-05-20 1997-06-12 Soltec Research Pty Ltd Sunscreen composition
AUPO983897A0 (en) * 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
ATE239488T1 (de) * 1998-02-02 2003-05-15 Boehringer Ingelheim Vetmed Verwendung von wirkstoffkombinationen aus antibiotika und terpenhaltigen pflanzenextrakten in der tiermedizin
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
JP4873513B2 (ja) * 1998-04-27 2012-02-08 ロンザ，インコーポレイティド アラビノガラクタンの誘導体類及びそれらを含む組成物
US6013637A (en) * 1998-06-12 2000-01-11 Dermik Laboratories Inc. Anti-acne method and composition
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
DE19855097A1 (de) * 1998-11-28 2000-05-31 Wella Ag Pigmenthaltiges, verschäumbares Gel
US7115277B2 (en) * 1999-03-04 2006-10-03 Allergan, Inc. Method for enabling delivery of an active agent
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US20030003170A1 (en) * 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
US6358541B1 (en) * 2000-05-03 2002-03-19 David S. Goodman Topical preparation for the treatment of hair loss
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US6428772B1 (en) * 2001-06-25 2002-08-06 Blistex Inc. Acne treatment composition with cooling effect
JP4458842B2 (ja) 2001-07-16 2010-04-28 富士通株式会社 周辺装置
HU0104790D0 (en) * 2001-11-08 2002-01-28 Human Rt Pharmaceutical combinations for topical application
FR2832311B1 (fr) * 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
US20040043946A1 (en) * 2002-09-03 2004-03-04 Popp Karl F. Topical formulations for treatment of skin disorders
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
EP1556009B2 (en) * 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US9265725B2 (en) * 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
MXPA05007722A (es) * 2003-01-24 2006-01-31 Connetics Australia Pty Ltd Espuma de fosfato de clindamicina.
ES2269858T3 (es) * 2003-04-28 2007-04-01 Biofrontera Bioscience Gmbh Utilizacion de riluzol combinado con sustancias auxiliares y aditivos adecuados pra el tratamiento de enfermedades, caracterizadas una hiperproliferacion de queratinocitos, en particular neurodermitis y psoriasis.
US20050014729A1 (en) * 2003-07-16 2005-01-20 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
EP1670435A2 (en) * 2003-08-04 2006-06-21 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
BRPI0412975A (pt) * 2003-08-25 2006-10-03 Foamix Ltd espuma penetrante para uso farmacêutico
ITMI20032019A1 (it) * 2003-10-17 2005-04-18 Fidia Farmaceutici Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono
CA2537029C (en) * 2003-11-26 2013-03-12 Likan Liang Micellar systems useful for delivery of lipophilic or hydrophobic compounds
EP1651199A4 (en) * 2004-02-13 2008-08-20 Pcr Technology Holdings Lc PROCESS AND PREPARATION REDUCING IRRITATION AND / OR INFLAMMATORY SKIN REACTIONS IN HUMANS
US20050238597A1 (en) * 2004-04-26 2005-10-27 Mccook John P Topical treatment of acne, seborrheic dermatitis, and oily skin with formulations containing histamine antagonists
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070196323A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs
US8907153B2 (en) * 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20070189977A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Spray-on formulations and methods for dermal delivery of drugs
AR051197A1 (es) * 2004-08-31 2006-12-27 Connetics Australia Pty Ltd Un procedimiento para obtener una microemulsion y sub-micron emulsion y composiciones
WO2006040644A2 (en) 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited Processes for the preparation of substituted thiochroman derivatives
TW200711649A (en) * 2005-06-17 2007-04-01 Combinatorx Inc Combination therapy for the treatment of immunoinflammatory disorders
US9393218B2 (en) * 2005-12-23 2016-07-19 Epinamics Gmbh Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
KR101333100B1 (ko) 2005-12-23 2013-11-27 에피나믹스 게엠베하 폴리우레탄 군으로부터의 필름-형성 헤어 케어 폴리머의 용도 및 폴리머를 포함하는 약학적 제제와 패치
WO2007082864A2 (en) 2006-01-20 2007-07-26 Polichem Sa Use of chavicol as an antiseptic
US7252816B1 (en) * 2006-03-29 2007-08-07 Dow Pharmaceutical Sciences Topical acne vulgairs medication with a sunscreen
EP2010133B1 (en) * 2006-03-31 2016-05-04 Stiefel Research Australia Pty Ltd Foamable suspension gel
WO2008075207A2 (en) 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20070280972A1 (en) * 2006-04-25 2007-12-06 Zars, Inc. Adhesive solid gel-forming formulations for dermal drug delivery
MXPA06008988A (es) 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
US20100076037A1 (en) 2006-11-02 2010-03-25 Chiang Lillian W Methods of Treating Neuropathic Pain with Agonists of PPAR-gamma
WO2008152444A2 (en) 2006-11-29 2008-12-18 Foamix Ltd. Foamable waterless compositions with modulating agents
EP1958613A1 (en) 2007-02-15 2008-08-20 Polichem S.A. Dermal film-forming liquid formulations for drug release to skin
DE102007059703A1 (de) 2007-02-28 2008-09-04 Henkel Ag & Co. Kgaa Wirkstoff-stabiliserte O/W-Emulsionen II
DE102007059704A1 (de) 2007-02-28 2008-09-04 Henkel Ag & Co. Kgaa Reinigende O/W-Emulsion
FR2915682B1 (fr) 2007-05-04 2009-07-03 Galderma Res & Dev Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations
WO2009029046A1 (en) 2007-08-29 2009-03-05 Agency For Science, Technology And Research Sugar-based surfactant microemulsions containing essential oils for cosmetic and pharmaceutical use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486394B2 (en) 2003-01-24 2016-11-08 Stiefel West Coast, Llc Pharmaceutical foam

Also Published As

Publication number Publication date
US20120074026A1 (en) 2012-03-29
BRPI0406905A (pt) 2005-12-13
US7749488B2 (en) 2010-07-06
TWI388322B (zh) 2013-03-11
NZ541526A (en) 2008-03-28
AU2009235974A1 (en) 2009-11-26
NO339620B1 (no) 2017-01-16
US7374747B2 (en) 2008-05-20
JP4828404B2 (ja) 2011-11-30
BRPI0406905B8 (pt) 2021-05-25
WO2004064833A1 (en) 2004-08-05
JP2006515362A (ja) 2006-05-25
US20100266511A1 (en) 2010-10-21
EP1592420A1 (en) 2005-11-09
JP2011225585A (ja) 2011-11-10
IL214118A0 (en) 2011-08-31
US7141237B2 (en) 2006-11-28
CA2513773C (en) 2013-03-26
NO20053577L (no) 2005-10-06
JP5480201B2 (ja) 2014-04-23
WO2004064833A8 (en) 2005-09-22
EA009031B1 (ru) 2007-10-26
US20060127321A1 (en) 2006-06-15
IL169761A (en) 2014-01-30
US8586008B2 (en) 2013-11-19
AU2004206769B2 (en) 2009-11-26
EA200701259A1 (ru) 2008-02-28
AR082432A2 (es) 2012-12-05
ES2637956T3 (es) 2017-10-18
EP2289512B8 (en) 2017-08-02
US20040151671A1 (en) 2004-08-05
IL214118A (en) 2015-04-30
ES2450133T3 (es) 2014-03-24
TW201043230A (en) 2010-12-16
RS20050557A (en) 2007-09-21
AU2004206769A1 (en) 2004-08-05
US20070077208A1 (en) 2007-04-05
EP2289512A1 (en) 2011-03-02
CA2513773A1 (en) 2004-08-05
MXPA05007722A (es) 2006-01-31
EP2289512B1 (en) 2017-06-07
NO20053577D0 (no) 2005-07-22
US20140042051A1 (en) 2014-02-13
EP1592420B1 (en) 2014-01-01
EA014372B1 (ru) 2010-10-29
TWI355267B (en) 2012-01-01
US9486394B2 (en) 2016-11-08
EA200501169A1 (ru) 2006-02-24
TW200420303A (en) 2004-10-16
BRPI0406905B1 (pt) 2019-10-08
EP1592420A4 (en) 2010-12-08
AU2009235974B2 (en) 2010-12-16

Similar Documents

Publication Publication Date Title
AR042906A1 (es) Espuma de fosfato de clindamicina sensible a la temperatura y metodo de tratamiento de acne que la utiliza
MX2009000507A (es) Espuma farmaceutica de acidos grasos.
PA8606201A1 (es) DERIVADOS DE PIRROLO[3,4-c) PIRAZOL ACTIVOS COMO INHIBIDORES DE QUINASA, PROCESO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN
CR10838A (es) Derivados de 2,3-dihidroimidazol [1,2-c] quinazolina sustituidos, de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis
WO2005009357A3 (en) Controlled release compositions
AR038535A1 (es) Formulaciones farmaceuticas de agentes antineoplasicos y procesos para prepararlos y usarlos
AR057422A1 (es) Uan composicion farmaceutica de liberacion modificada, proceso de preparacion de dicha composicion y metodo para emplear la misma
AR025763A1 (es) Metodos y sistemas para el tratamiento del tejido enfermo con composiciones antiinfecciosas
TW200626558A (en) Indazolone derivatives
AR040758A1 (es) Un producto de limpieza de espuma extruido y un proceso para producir un producto
AR037718A1 (es) Un sistema de control de olor, una capa absorbente para un articulo absorbente, un articulo absorbente tal como un panal y similares que comprenden dicho sistema
AR029462A1 (es) Derivados del acido picolinico, procedimiento para prepararlos y composiciones formuladas con dichos derivados como agente activo, procedimientos preventivos o curativos contra hongos fitopatogenos, metodos preventivos o de tratamiento de la madera para la construccion utilizando dichos compuestos y
WO2009087578A3 (en) Sensation modifying topical composition foam
AR018143A1 (es) Formulacion para preparar un comprimido de desintegracion rapida, comprimidos de desintegracion rapida, especialmente comprimidos de desintegracionrapida en la boca
CR9351A (es) Composiciones y metodos para aplicaicon topica y suministro transdermico de toxina botulinica
PA8576201A1 (es) Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco
GB0421900D0 (en) Inhibition of tumour cell migration
MX2007011908A (es) Metodo basado en el suministro local de sustancias activas para tratar enfermedades prostaticas.
DOP2002000389A (es) Metodo para fabricar una composición farmaceutica de dosis baja que tiene una distribución y potencia del fármaco uniforme
MX2008008413A (es) Composicion farmaceutica para el tratamiento de las enfermedades de las uñas.
AR044660A1 (es) Composiciones farmaceuticas de atorvastatina
EP4218803A3 (en) Foam-forming compositions and methods for delivering an active agent to a body cavity
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
AR048050A1 (es) Formas de administracion masticables, no comprimidas, dosificadas individualmente
AR052048A1 (es) Composiciones farmaceuticas para el tratamiento de la celulitis

Legal Events

Date Code Title Description
FC Refusal